+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

D-Biotin Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082833
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The D-Biotin Market grew from USD 636.73 million in 2024 to USD 698.01 million in 2025. It is expected to continue growing at a CAGR of 9.54%, reaching USD 1.10 billion by 2030.

D-Biotin, a water-soluble B vitamin, has emerged as a cornerstone ingredient across cosmetics, food and beverage fortification, and pharmaceutical formulations. Revered for its role in promoting healthy hair, skin, and nails, it also serves as an essential cofactor in metabolic processes when included in dietary supplements. In recent years, heightened consumer interest in wellness, coupled with technological advances in formulation science, has amplified demand for high-purity D-Biotin. Manufacturers are navigating a landscape defined by stricter regulatory frameworks, evolving supply chain dynamics, and intensifying competition from both established chemical suppliers and emerging biotechnology firms. This executive summary synthesizes the pivotal trends shaping the D-Biotin market, examines the disruptive influence of new trade measures, and distills insights from key segmentation, region-specific performance, and competitive positioning. By unpacking these critical dimensions, decision-makers and industry experts can chart a strategic course that leverages innovation and resilience as drivers of growth.

Transformative Shifts Redefining the D-Biotin Landscape

The D-Biotin landscape is undergoing profound transformation driven by an interplay of consumer preferences, regulatory advances, and technological breakthroughs. First, the convergence of personalized nutrition and precision beauty has spurred the development of novel delivery systems such as micro-encapsulated powders and sustained-release topicals, enabling targeted efficacy and enhanced bioavailability. Second, tightened regulations in major markets have elevated quality benchmarks for purity, traceability, and manufacturing practices, compelling suppliers to invest in ISO-certified facilities and blockchain-backed trace documentation. Third, sustainability imperatives are reshaping raw material sourcing, prompting key players to adopt renewable feedstocks and lifecycle-optimized processes. Fourth, digitalization has redefined go-to-market strategies: data analytics and AI-driven consumer insights are informing formulation design and marketing personalization. Finally, cross-sector collaborations between biotech startups and legacy chemical companies are accelerating innovation cycles, positioning D-Biotin to address emerging applications in gut health and immune support. Together, these shifts are recalibrating competitive dynamics and creating new value pathways across the value chain.

Cumulative Impact of United States Tariffs on D-Biotin Imports 2025

In 2025, the United States implemented additional tariffs on D-Biotin imports, cumulatively reaching levels that exceed 25 percent in several categories. These adjustments have reverberated across the supply chain. Importers reliant on cost-effective offshore production have faced immediate margin compression, driving up landed costs for both cosmetic-grade and pharmaceutical-grade biotin. In response, some manufacturers have accelerated qualification of domestic suppliers, catalyzing capacity investments in North American production facilities. Meanwhile, brands with vertically integrated operations are leveraging in-house synthesis capabilities to mitigate exposure to tariff volatility. Despite these strategic pivots, smaller formulation houses without internal manufacturing face tighter margins, passing a portion of elevated costs to end consumers. Over time, the tariffs are expected to spur consolidation among mid-tier distributors and encourage partnerships that combine local production with global distribution networks. While short-term cost inflation poses challenges, the evolving tariff environment also presents opportunities for domestic capacity expansion and the emergence of high-purity, tariff-exempt biotin derivatives tailored to specialized niches.

Key Segmentation Insights Unveiling Market Dynamics for D-Biotin

Evaluation of the D-Biotin market through multiple segmentation lenses uncovers differentiated growth drivers. When dissected by product type, cosmetic grade formulations-offered as creams, lotions, and serums-continue to gain traction as clean-beauty brands spotlight biotin’s fortifying properties. Food-grade variants in liquid form, powdered form, and tablet form are increasingly incorporated into fortified beverages and functional foods, reflecting a consumer shift toward preventive wellness. Pharmaceutical grade biotin, available in injectable, oral dose, and topical solutions, remains integral to specialty therapies and clinical research. From an application standpoint, cosmetics and personal care producers leverage D-Biotin variants engineered for hair care, nail health, and skin revitalization, while food and beverage manufacturers integrate it into dietary additives, fortified beverages, and functional foods. The pharmaceutical segment sees strong uptake in dietary supplements, immune boosters, and nutritional products designed for targeted population health. Shifting focus to the end-user industry, manufacturers of personal care companies and salon-and-spa channels are collaborating with raw material suppliers to introduce salon-grade biotin serums. Beverage companies and nutraceutical firms are optimizing flavored biotin formulations to enhance palatability. Within the healthcare sector, clinics and research institutes pilot novel biotin analogs in metabolic studies, expanding the scope of therapeutic applications. The formulation perspective uncovers dynamic innovation in capsule, liquid, and topical forms. Immediate release and sustained release capsules grant dosage flexibility, while concentrates and solution drops enable precision dosing for at-home regimens. Topical formats-including creams, gels, and ointments-are being reformulated with bio-enhancers to improve transdermal absorption. Lastly, distribution channels illustrate a clear trend toward direct-to-consumer websites and e-commerce platforms, complemented by traditional wholesale relationships with B2B partners, cosmetic retail outlets, health stores, pharmacy chains, and omnichannel retail networks.

Regional Dynamics Shaping Demand and Supply of D-Biotin Globally

Regional dynamics exert a profound influence on both demand and supply structures. In the Americas, robust consumer spending on premium skincare and supplements underpins sustained biotin uptake, while regulatory frameworks in the United States and Canada incentivize domestic manufacturing and quality assurance. Europe, the Middle East & Africa exhibit a diverse regulatory landscape: stringent European Union purity standards coexist with emerging MENA markets that prioritize cost-effective wellness solutions, creating a two-tiered demand profile. The Asia-Pacific region remains the fastest-growing, driven by rising disposable incomes, growing beauty aspirations, and expanding retail infrastructure in countries such as China, India, South Korea, and Japan. Here, local suppliers are scaling up capacity to meet demand for both food-grade and pharmaceutical-grade biotin, and government initiatives aimed at nutritional fortification are bolstering product adoption. Across all regions, a convergence toward high-purity, traceable supply chains is evident, as end users increasingly prioritize safety and efficacy.

Key Company Insights Driving Competitive Trends in D-Biotin

The competitive arena is defined by a diverse mix of multinational corporations, specialty chemical firms, and biotechnology innovators. Merck KGaA maintains leadership in high-purity D-Biotin production, leveraging advanced fermentation and purification technologies to serve pharmaceutical clients. Royal DSM has intensified focus on sustainable sourcing, integrating green chemistry principles across its biotin portfolio. Creative Enzymes and Dastech International have distinguished themselves through custom enzyme synthesis, facilitating tailored biotin derivatives for niche applications. Central Drug House, Cepham Life Sciences, and Foodchem International Corporation capitalize on wide distribution networks to meet bulk demand. Creative enzymes provider Hangzhou Kexing Biochem and specialty reagent supplier Biotium, Inc. are pioneering bio-enhanced formulations. Loba Chemie and Otto Chemie have strengthened global partnerships to streamline raw material availability for cosmetic and nutraceutical customers. Manus Aktteva Biopharma and Sisco Research Laboratories focus on R&D collaboration, enabling breakthroughs in sustained-release and injectable formats. Vizag Chemicals and Wellona Pharma offer cost-competitive solutions, targeting emerging markets, while VWR International by Avantor ensures seamless supply chain integration for research institutes. Fengchen Group, Parchem Fine & Specialty Chemicals, Shanghai Acebright Pharmaceuticals, and Zhejiang Shengda Bio-Pharm emphasize scale, regulatory compliance, and rapid order fulfillment. Hugestone Enterprise, Loba, Samex Overseas and Salvavidas Pharmaceutical optimize pan-regional logistics, catering to distributors in Latin America, MENA, and Asia-Pacific. Collectively, these players navigate a balance between quality, innovation, and cost efficiency, shaping the trajectory of the global D-Biotin ecosystem.

Actionable Recommendations for Industry Leaders to Capitalize on D-Biotin Opportunities

Industry leaders should immediately prioritize diversification of supply sources to mitigate tariff exposure and geopolitical risk, balancing onshore capacity with strategic partnerships in low-cost regions. Investment in sustainable feedstock and green manufacturing will not only satisfy regulatory and consumer expectations, but also future-proof operations against resource constraints. Formulation innovation-particularly in micro-encapsulation, sustained-release capsules, and transdermal delivery systems-will unlock premium margins and differentiate offerings in crowded markets. Expanding digital engagement through direct-to-consumer platforms and AI-driven personalization can boost brand loyalty and streamline product development cycles. Collaborating with research institutes and clinical centers to validate novel biotin applications, such as immune support and metabolic health, will strengthen claims substantiation and accelerate market uptake. Lastly, agile pricing strategies that account for tariff fluctuations and raw material cost swings will preserve margins while maintaining competitive positioning.

Conclusion

The D-Biotin market continues to evolve under the influence of technological innovation, regulatory rigor, and shifting consumer aspirations. Companies that proactively adapt through supply chain agility, sustainable practices, and targeted formulation R&D will emerge as market leaders. The interplay between tariff developments and regional growth trajectories underscores the need for strategic foresight and nimble execution. As competitive intensity rises, success will hinge on the ability to deliver high-purity, application-tailored solutions that resonate with both B2B partners and end consumers.

Market Segmentation & Coverage

This research report categorizes the D-Biotin Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Cosmetic Grade
    • Creams
    • Lotions
    • Serum
  • Food Grade
    • Liquid Form
    • Powdered Form
    • Tablet Form
  • Pharmaceutical Grade
    • Injectable
    • Oral Dose
    • Topical Solutions
  • Cosmetics and Personal Care
    • Haircare
    • Nail Health
    • Skincare
  • Food and Beverages
    • Dietary Additives
    • Fortified Beverages
    • Functional Foods
  • Pharmaceuticals
    • Dietary Supplements
    • Immune Boosters
    • Nutritional Products
  • Cosmetics Industry
    • Cosmetic Products Manufacturers
    • Personal Care Companies
    • Salons and Spas
  • Food Industry
    • Beverage Companies
    • Food Manufacturers
    • Nutraceutical Firms
  • Healthcare Sector
    • Clinics
    • Hospitals
    • Research Institutes
  • Capsule Formulation
    • Immediate Release
    • Sustained Release
  • Liquid Formulation
    • Concentrates
    • Solution Drops
  • Topical Formulation
    • Creams
    • Gels
    • Ointments
  • Business to Business (B2B)
    • Wholesale
  • Offline Retail
    • Cosmetic Retail Outlets
    • Health Stores
    • Pharmacy Chains
  • Online Retail
    • Direct-to-Consumer Websites
    • E-commerce Platforms

This research report categorizes the D-Biotin Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the D-Biotin Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Biotium, Inc.
  • Central Drug House Pvt. Ltd.
  • Cepham Life Sciences
  • Creative Enzymes
  • Dastech International Inc.
  • Fengchen Group Co.,Ltd
  • Foodchem International Corporation
  • Glentham Life Sciences Limited
  • Hangzhou Kexing Biochem Co.,Ltd.
  • Hugestone Enterprise Co., Ltd.
  • Loba Chemie Pvt. Ltd.
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Otto Chemie Pvt. Ltd.
  • Parchem Fine & Specialty Chemicals
  • Royal DSM
  • Salvavidas Pharmaceutical Private Limited
  • Samex Overseas
  • Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • Shanghai Acebright Pharmaceuticals Group Co., Ltd.
  • Sisco Research Laboratories Pvt. Ltd.
  • Vizag Chemicals
  • VWR International, LLC by Avantor, Inc.
  • Wellona Pharma
  • Zhejiang Shengda Bio-Pharm Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. D-Biotin Market, by Product Type
8.1. Introduction
8.2. Cosmetic Grade
8.2.1. Creams
8.2.2. Lotions
8.2.3. Serum
8.3. Food Grade
8.3.1. Liquid Form
8.3.2. Powdered Form
8.3.3. Tablet Form
8.4. Pharmaceutical Grade
8.4.1. Injectable
8.4.2. Oral Dose
8.4.3. Topical Solutions
9. D-Biotin Market, by Application
9.1. Introduction
9.2. Cosmetics and Personal Care
9.2.1. Haircare
9.2.2. Nail Health
9.2.3. Skincare
9.3. Food and Beverages
9.3.1. Dietary Additives
9.3.2. Fortified Beverages
9.3.3. Functional Foods
9.4. Pharmaceuticals
9.4.1. Dietary Supplements
9.4.2. Immune Boosters
9.4.3. Nutritional Products
10. D-Biotin Market, by End-User Industry
10.1. Introduction
10.2. Cosmetics Industry
10.2.1. Cosmetic Products Manufacturers
10.2.2. Personal Care Companies
10.2.3. Salons and Spas
10.3. Food Industry
10.3.1. Beverage Companies
10.3.2. Food Manufacturers
10.3.3. Nutraceutical Firms
10.4. Healthcare Sector
10.4.1. Clinics
10.4.2. Hospitals
10.4.3. Research Institutes
11. D-Biotin Market, by Formulation
11.1. Introduction
11.2. Capsule Formulation
11.2.1. Immediate Release
11.2.2. Sustained Release
11.3. Liquid Formulation
11.3.1. Concentrates
11.3.2. Solution Drops
11.4. Topical Formulation
11.4.1. Creams
11.4.2. Gels
11.4.3. Ointments
12. D-Biotin Market, by Distribution Channel
12.1. Introduction
12.2. Business to Business (B2B)
12.2.1. Wholesale
12.3. Offline Retail
12.3.1. Cosmetic Retail Outlets
12.3.2. Health Stores
12.3.3. Pharmacy Chains
12.4. Online Retail
12.4.1. Direct-to-Consumer Websites
12.4.2. E-commerce Platforms
13. Americas D-Biotin Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific D-Biotin Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa D-Biotin Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Biotium, Inc.
16.3.2. Central Drug House Pvt. Ltd.
16.3.3. Cepham Life Sciences
16.3.4. Creative Enzymes
16.3.5. Dastech International Inc.
16.3.6. Fengchen Group Co.,Ltd
16.3.7. Foodchem International Corporation
16.3.8. Glentham Life Sciences Limited
16.3.9. Hangzhou Kexing Biochem Co.,Ltd.
16.3.10. Hugestone Enterprise Co., Ltd.
16.3.11. Loba Chemie Pvt. Ltd.
16.3.12. Manus Aktteva Biopharma LLP
16.3.13. Merck KGaA
16.3.14. Otto Chemie Pvt. Ltd.
16.3.15. Parchem Fine & Specialty Chemicals
16.3.16. Royal DSM
16.3.17. Salvavidas Pharmaceutical Private Limited
16.3.18. Samex Overseas
16.3.19. Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
16.3.20. Shanghai Acebright Pharmaceuticals Group Co., Ltd.
16.3.21. Sisco Research Laboratories Pvt. Ltd.
16.3.22. Vizag Chemicals
16.3.23. VWR International, LLC by Avantor, Inc.
16.3.24. Wellona Pharma
16.3.25. Zhejiang Shengda Bio-Pharm Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. D-BIOTIN MARKET MULTI-CURRENCY
FIGURE 2. D-BIOTIN MARKET MULTI-LANGUAGE
FIGURE 3. D-BIOTIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL D-BIOTIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL D-BIOTIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL D-BIOTIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL D-BIOTIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL D-BIOTIN MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL D-BIOTIN MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES D-BIOTIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES D-BIOTIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA D-BIOTIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. D-BIOTIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. D-BIOTIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. D-BIOTIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL D-BIOTIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL D-BIOTIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL D-BIOTIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL D-BIOTIN MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL D-BIOTIN MARKET SIZE, BY LOTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL D-BIOTIN MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL D-BIOTIN MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL D-BIOTIN MARKET SIZE, BY POWDERED FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL D-BIOTIN MARKET SIZE, BY TABLET FORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL D-BIOTIN MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL D-BIOTIN MARKET SIZE, BY ORAL DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL D-BIOTIN MARKET SIZE, BY TOPICAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL D-BIOTIN MARKET SIZE, BY HAIRCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL D-BIOTIN MARKET SIZE, BY NAIL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL D-BIOTIN MARKET SIZE, BY SKINCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL D-BIOTIN MARKET SIZE, BY DIETARY ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL D-BIOTIN MARKET SIZE, BY FORTIFIED BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL D-BIOTIN MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL D-BIOTIN MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL D-BIOTIN MARKET SIZE, BY IMMUNE BOOSTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL D-BIOTIN MARKET SIZE, BY NUTRITIONAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETIC PRODUCTS MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL D-BIOTIN MARKET SIZE, BY PERSONAL CARE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL D-BIOTIN MARKET SIZE, BY SALONS AND SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL D-BIOTIN MARKET SIZE, BY BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL D-BIOTIN MARKET SIZE, BY NUTRACEUTICAL FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL D-BIOTIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL D-BIOTIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL D-BIOTIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL D-BIOTIN MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL D-BIOTIN MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL D-BIOTIN MARKET SIZE, BY CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL D-BIOTIN MARKET SIZE, BY SOLUTION DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL D-BIOTIN MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL D-BIOTIN MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL D-BIOTIN MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL D-BIOTIN MARKET SIZE, BY WHOLESALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 72. GLOBAL D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL D-BIOTIN MARKET SIZE, BY COSMETIC RETAIL OUTLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL D-BIOTIN MARKET SIZE, BY HEALTH STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL D-BIOTIN MARKET SIZE, BY PHARMACY CHAINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL D-BIOTIN MARKET SIZE, BY DIRECT-TO-CONSUMER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL D-BIOTIN MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 99. AMERICAS D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS D-BIOTIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 140. BRAZIL D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 142. CANADA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 144. CANADA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 145. CANADA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 146. CANADA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. CANADA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 148. CANADA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 149. CANADA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 150. CANADA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 151. CANADA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 152. CANADA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 153. CANADA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 154. CANADA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 155. CANADA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. CANADA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. CANADA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. CANADA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. CANADA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 160. CANADA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 161. CANADA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 162. MEXICO D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. MEXICO D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 164. MEXICO D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 166. MEXICO D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. MEXICO D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 168. MEXICO D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. MEXICO D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 171. MEXICO D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 172. MEXICO D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 173. MEXICO D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 174. MEXICO D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 175. MEXICO D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. MEXICO D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. MEXICO D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. MEXICO D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. MEXICO D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 180. MEXICO D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 181. MEXICO D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES D-BIOTIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC D-BIOTIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 239. AUSTRALIA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 240. AUSTRALIA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. AUSTRALIA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 244. CHINA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. CHINA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 246. CHINA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 247. CHINA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 248. CHINA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. CHINA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 250. CHINA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 251. CHINA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 252. CHINA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 253. CHINA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 254. CHINA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 255. CHINA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 256. CHINA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. CHINA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 258. CHINA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 259. CHINA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 260. CHINA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. CHINA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 262. CHINA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 263. CHINA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 264. INDIA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. INDIA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 266. INDIA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 267. INDIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 268. INDIA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. INDIA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 270. INDIA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 271. INDIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. INDIA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 273. INDIA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 274. INDIA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 275. INDIA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 276. INDIA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 277. INDIA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 278. INDIA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 279. INDIA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 280. INDIA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. INDIA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 282. INDIA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 283. INDIA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 284. INDONESIA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDONESIA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 286. INDONESIA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 287. INDONESIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 288. INDONESIA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. INDONESIA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 290. INDONESIA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 291. INDONESIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 292. INDONESIA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 293. INDONESIA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 294. INDONESIA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 295. INDONESIA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 296. INDONESIA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 297. INDONESIA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 298. INDONESIA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 299. INDONESIA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 300. INDONESIA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. INDONESIA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 302. INDONESIA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 303. INDONESIA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 304. JAPAN D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. JAPAN D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 306. JAPAN D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 307. JAPAN D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 308. JAPAN D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. JAPAN D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 310. JAPAN D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 311. JAPAN D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 312. JAPAN D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 313. JAPAN D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 314. JAPAN D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 315. JAPAN D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 316. JAPAN D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 317. JAPAN D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. JAPAN D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 319. JAPAN D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 320. JAPAN D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. JAPAN D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 322. JAPAN D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 323. JAPAN D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 324. MALAYSIA D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 325. MALAYSIA D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 326. MALAYSIA D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 327. MALAYSIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 328. MALAYSIA D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. MALAYSIA D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 330. MALAYSIA D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 331. MALAYSIA D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 332. MALAYSIA D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 333. MALAYSIA D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 334. MALAYSIA D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 335. MALAYSIA D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 336. MALAYSIA D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 337. MALAYSIA D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 338. MALAYSIA D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. MALAYSIA D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 341. MALAYSIA D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 342. MALAYSIA D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 343. MALAYSIA D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 346. PHILIPPINES D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 347. PHILIPPINES D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 348. PHILIPPINES D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. PHILIPPINES D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 350. PHILIPPINES D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 351. PHILIPPINES D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 352. PHILIPPINES D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 353. PHILIPPINES D-BIOTIN MARKET SIZE, BY COSMETICS INDUSTRY, 2018-2030 (USD MILLION)
TABLE 354. PHILIPPINES D-BIOTIN MARKET SIZE, BY FOOD INDUSTRY, 2018-2030 (USD MILLION)
TABLE 355. PHILIPPINES D-BIOTIN MARKET SIZE, BY HEALTHCARE SECTOR, 2018-2030 (USD MILLION)
TABLE 356. PHILIPPINES D-BIOTIN MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 357. PHILIPPINES D-BIOTIN MARKET SIZE, BY CAPSULE FORMULATION, 2018-2030 (USD MILLION)
TABLE 358. PHILIPPINES D-BIOTIN MARKET SIZE, BY LIQUID FORMULATION, 2018-2030 (USD MILLION)
TABLE 359. PHILIPPINES D-BIOTIN MARKET SIZE, BY TOPICAL FORMULATION, 2018-2030 (USD MILLION)
TABLE 360. PHILIPPINES D-BIOTIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 361. PHILIPPINES D-BIOTIN MARKET SIZE, BY BUSINESS TO BUSINESS (B2B), 2018-2030 (USD MILLION)
TABLE 362. PHILIPPINES D-BIOTIN MARKET SIZE, BY OFFLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 363. PHILIPPINES D-BIOTIN MARKET SIZE, BY ONLINE RETAIL, 2018-2030 (USD MILLION)
TABLE 364. SINGAPORE D-BIOTIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 365. SINGAPORE D-BIOTIN MARKET SIZE, BY COSMETIC GRADE, 2018-2030 (USD MILLION)
TABLE 366. SINGAPORE D-BIOTIN MARKET SIZE, BY FOOD GRADE, 2018-2030 (USD MILLION)
TABLE 367. SINGAPORE D-BIOTIN MARKET SIZE, BY PHARMACEUTICAL GRADE, 2018-2030 (USD MILLION)
TABLE 368. SINGAPORE D-BIOTIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 369. SINGAPORE D-BIOTIN MARKET SIZE, BY COSMETICS AND PERSONAL CARE, 2018-2030 (USD MILLION)
TABLE 370. SINGAPORE D-BIOTIN MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2030 (USD MILLION)
TABLE 371. SINGAPORE D-BIOTIN MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 372. SINGAPORE D-BIOTIN MARKET SIZE, BY END-USER INDUSTRY, 2018-2030 (USD MILLION)
TABLE 373. SINGAPORE D-BIOTIN MARKET SIZE, BY COS

Companies Mentioned

  • Biotium, Inc.
  • Central Drug House Pvt. Ltd.
  • Cepham Life Sciences
  • Creative Enzymes
  • Dastech International Inc.
  • Fengchen Group Co.,Ltd
  • Foodchem International Corporation
  • Glentham Life Sciences Limited
  • Hangzhou Kexing Biochem Co.,Ltd.
  • Hugestone Enterprise Co., Ltd.
  • Loba Chemie Pvt. Ltd.
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Otto Chemie Pvt. Ltd.
  • Parchem Fine & Specialty Chemicals
  • Royal DSM
  • Salvavidas Pharmaceutical Private Limited
  • Samex Overseas
  • Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
  • Shanghai Acebright Pharmaceuticals Group Co., Ltd.
  • Sisco Research Laboratories Pvt. Ltd.
  • Vizag Chemicals
  • VWR International, LLC by Avantor, Inc.
  • Wellona Pharma
  • Zhejiang Shengda Bio-Pharm Co., Ltd.

Methodology

Loading
LOADING...